Parvovirus B19 (Human), IgG/IgM

Alphabetical Test listing

Parvovirus B19 (Human), IgG/IgM-13537

Test name:

Test number:

13537

Excellian order number:

LAB13537

Abbreviation:

PARVOB19AB

Alternate names:

Human Parvovirus B19, IgG, IgM

Useful for:

Differential diagnosis of acute or recent infection from past infection with human parvovirus associated with erythema infectiosum (fifth disease), aplastic crisis, and fetal infection.

Specimen type:

Serum

Collection container:

Gold serum separator (SST) tube

Volume:

1.0 mL

Minimum volume:

0.5 mL

Collection instructions:

Immediately following collection, thoroughly mix sample by gently inverting 5 times

Processing instructions:

Allow sample to clot for a minimum of 30 minutes
Spin within two (2) hours of sample collection

Transport container:

Gold serum separator (SST) tube

Alternate collection container:

Red serum vial/tube, 5 mL

Alternate processing instructions:

Allow sample to clot
Spin
Transfer serum to a Transfer vial/tube with cap - 12mL (LabCorp), labelled as serum, within two (2) hours of sample collection

Alternate transport container:

Transfer vial/tube with cap - 12mL (LabCorp)

Transport and stability:

Ambient (preferred) - 14 days

Refrigerated - 14 days

Frozen - 14 days

Freeze/thaw cycles - stable x3

Reason for rejection:

Hemolysis
Lipemia
Gross bacterial contamination

Performing lab:

LabCorp Burlington (163303): R-LC

Days set up:

Mo - Fr

TAT:

5 days

Method:

Enzyme immunoassay (EIA)

Reference ranges:

Negative:

IgG: < 0.9 index

IgM: < 0.9 index

Clinical information:

IgM antibodies are detectable two weeks after exposure. IgG antibody production usually occurs 18 to 24 days after exposure. The presence of IgM antibodies to parvovirus B19 provides definite evidence of recent infection.

CPT codes:

86747 x 2

LOINC code:

Result 5273-8

Date created:

04/10/2019

Revised date:

04/11/2022

Review date:

04/05/2022